Skip to main content

The electroretinogram b-wave amplitude: a differential physiological measure for Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder



Attention Deficit Hyperactivity Disorder (ADHD) is the most prevalent childhood neurodevelopmental disorder. It shares some genetic risk with Autism Spectrum Disorder (ASD), and the conditions often occur together. Both are potentially associated with abnormal glutamate and GABA neurotransmission, which can be modelled by measuring the synaptic activity in the retina with an electroretinogram (ERG). Reduction of retinal responses in ASD has been reported, but little is known about retinal activity in ADHD. In this study, we compared the light-adapted ERGs of individuals with ADHD, ASD and controls to investigate whether retinal responses differ between these neurodevelopmental conditions.


Full field light-adapted ERGs were recorded from 15 ADHD, 57 ASD (without ADHD) and 59 control participants, aged from 5.4 to 27.3 years old. A Troland protocol was used with a random series of nine flash strengths from −0.367 to 1.204 log photopic cd.s.m−2. The time-to-peak and amplitude of the a- and b-waves and the parameters of the Photopic Negative Response (PhNR) were compared amongst the three groups of participants, using generalised estimating equations.


Statistically significant elevations of the ERG b-wave amplitudes, PhNR responses and faster timings of the b-wave time-to-peak were found in those with ADHD compared with both the control and ASD groups. The greatest elevation in the b-wave amplitudes associated with ADHD were observed at 1.204 log phot cd.s.m−2 flash strength (p < .0001), at which the b-wave amplitude in ASD was significantly lower than that in the controls. Using this measure, ADHD could be distinguished from ASD with an area under the curve of 0.88.


The ERG b-wave amplitude appears to be a distinctive differential feature for both ADHD and ASD, which produced a reversed pattern of b-wave responses. These findings imply imbalances between glutamate and GABA neurotransmission which primarily regulate the b-wave formation. Abnormalities in the b-wave amplitude could provisionally serve as a biomarker for both neurodevelopmental conditions.


Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition and one of the most common mental disorders in children and adolescents [1], affecting approximately 5% of children worldwide [2,3,4]. The characteristics of individuals with ADHD include inattention, hyperactivity and impulsivity [4]. Many children with ADHD continue to show symptoms in adolescence and adulthood, frequently struggling with various aspects of their lives [5, 6]. ADHD in adults has historically been underdiagnosed and has received less research attention than childhood ADHD [7]. ADHD is associated with delayed cortical maturation in many regions of the brain, including the visual cortex [8, 9]. ADHD has a strong biological underpinning, including alterations in the dopaminergic neurotransmitter system, leading to neuropsychological deficits [10] and affecting attention, working memory and aspects of visual perception such as colour discrimination, visual search and visual processing speed [10,11,12], along with the potential impact of these visual problems on education in children and on working or driving performances in adults [13].

Autism Spectrum Disorder (ASD) is also a neurodevelopmental disorder characterised by persistent deficits in co-occurring impairments of social reciprocity and social communication, repetitive patterns of behaviour and atypical responses to sensory input or unusual interests in aspects of the environment [4, 14]. Both ADHD and ASD exhibit some genetic and behavioural overlap and have abnormalities in similar brain systems, in particular the frontal and cerebellar regions [15]. Both disorders are highly heritable and share high comorbidity [16, 17]. Between 20–50% of children with ADHD have ASD traits and 30–80% of ASD children have co-occurring ADHD [17,18,19]. For years, ADHD-related deficits in ASD were considered a phenocopy, which prevented their formal co-diagnosis in both DSM-IV and ICD-10 [15, 20]. This diagnostic rule is no longer applied in DSM-5 or ICD-11 [4, 15]. Disorder-specific physiological biomarkers that differentiate these two conditions could further our understanding of their underlying neurobiology and their relative contribution to an individual’s phenotype.

The eye and neural retina provide a window to the neurobiology of the brain and have been of growing interest to those studying neurodegenerative and psychiatric disorders [21,22,23,24,25,26,27]. The retina has three highly organised cellular layers that are interconnected by two synaptic layers (see Fig. 1). Normal retinal neural function depends, like elsewhere in the brain, upon the balance of GABAergic (inhibitory) and glutamatergic (excitatory) neurotransmission. The synaptic networks in the retina change according to the strength of the background or flashed light. Under light-adapted (LA) conditions, the retinal networks are driven by the hyperpolarisation of light-activated cone photoreceptors, which synapse with a triad of cells: ON- and OFF-bipolar cells and horizontal cells [28]. Cone cell hyperpolarisation reduces the glutamate released to the ON- and OFF-bipolar cells. These bipolar cells contain different types of glutamate receptors which produce opposite responses to glutamate. ON-bipolar cells use slower metabotropic (ligand sensitive) glutamate receptors (primarily mGLUR6) that invert the cone hyperpolarisation into depolarisation. In contrast, OFF-bipolar cells use fast ionotropic glutamate receptors (iGLUR4, ligand-gated cation channels of the AMPA/Kainate class) that conserve hyperpolarisation [29]. Glutamate thus regulates excitatory signalling between the cones and bipolar cells. GABA, the most abundant inhibitory neurotransmitter in the brain, is presumed to allow the horizontal cells in the retina to modulate the balance and timing and gain of the cone signalling pathways [30].

Fig. 1
figure 1

Schematic diagram of the retinal pathway generating the electroretinogram in response to light. The schematic diagram displays the cellular component of the retina and the retinal pathway in response to light generating the electroretinogram (ERG) waveform. Light passes through the transparent retinal layers before reaching the photoreceptor chromophores which absorb the photons. The cone photoreceptor outer segment subsequently hyperpolarises, shutting off glutamate release into the post photoreceptor synapse. This hyperpolarisation is recorded as the a-wave in the electroretinogram waveform. Glutamate has opposite effects on the ON- and OFF-bipolar cells. Decreased glutamate binding on the mGLUR6 receptor starts a cascade of signals that open the transient receptor potential cation channel, subfamily M, member 1 (TRPM1) channel which depolarises the ON-bipolar cells and increases glutamate release to the ON-ganglion cell [31]. In contrast, the OFF-bipolar cell becomes hyperpolarised by the reduction of glutamate release from the cone cell binding on the iGLUR4 receptor, resulting in decreased glutamate release toward the OFF-ganglion cell. The b-wave amplitude is the summation of ON- and OFF-bipolar cell responses. The Photopic Negative Response (PhNR) is the summation of ON- and OFF-ganglion cell responses and contributions of Müller cell potassium currents. Glu, glutamate release; red arrow pointing down means reduced; mGLUR6, metabotropic glutamate receptor 6; iGLUR4, ionotropic glutamate receptor 4. Retinal layers: OS, Outer Segment; ON, Outer Nuclear; OP, Outer Plexiform; IN, Inner Nuclear; IP, Inner Plexiform; GC, Ganglion Cell

Light entering the eye causes retinal cell membranes to hyperpolarise and depolarise at different times. The net signal can be recorded at the front of the eye as the electroretinogram (ERG) waveform. This can be observed as a voltage change over time following the onset of a light flash (see Fig. 2). The ERG waveform has three features, each of which has distinct cellular origins. The first negative trough is called the a-wave and reflects the rapid hyperpolarisation of cone photoreceptors and the associated OFF-bipolar cells. It is followed by the b-wave, a positive peak which reflects the slower depolarisation of the ON-bipolar cells and the recovery repolarisation of the hyperpolarised OFF-bipolar cells. The third feature is the trough after the b-wave termed the photopic negative response (PhNR) which is associated with retinal ganglion cell activity [32,33,34], mediated by potassium currents in the Müller glia cells which extend through the retina [35]. Changes in the size and timing of the peaks and troughs of the ERG reflect the proportionate contributions of specific retinal cells in signalling the onset and offset of a flash of light and the balance of glutamate and GABA neurotransmission responding to that stimulus.

Fig. 2
figure 2

Different parameters of the ERG waveform. The ERG response starts at time 0 followed by the a-wave, b-wave, and Photopic Negative Response (PhNR). Description of the ERG waveform parameters: a-amp, a-wave amplitude, an amplitude from the baseline to the a-wave trough; a-time, a-wave time-to-peak, from the light onset to a-wave trough; b-amp, b-wave amplitude, measured from a-wave trough to b-wave peak; b-time, b-wave time-to-peak, from the light onset to the time when the b-wave amplitude peaks; p72, PhNR amplitude from baseline to the waveform at 72 ms post-stimulus onset; PhNRmin, PhNR amplitude measured as the most negative point from the baseline within the time window of 55 and 95 ms following stimulus onset; Tmin, time of PhNR at a minimal amplitude occurred within the 55–95-ms window

The ERG is increasingly being used to distinguish between psychiatric conditions, such as schizophrenia from bipolar disorder, and to investigate the effects of drug treatment in conditions such as depression [36,37,38,39,40,41]. In children and adults with ASD, reduced ERG b-wave amplitudes, compared to those of typical controls, have been observed under both dark-adapted (DA) and LA conditions and are considered to reflect an imbalance in glutamate and GABA signalling [42,43,44,45]. In ADHD, not much is known about the retina’s response to light, though increased background retinal noise was reported recently [1, 46]. The origin of the background retinal noise in ADHD is unexplained, but it correlates with measures of inattention symptoms [1, 47]. Reports show an association of the genetic variants involved in glutamate neurotransmission with the severity of hyperactivity and impulsivity, implying a role for ionotropic and metabolic glutamate receptors in the pathogenesis of ADHD [48, 49].

In this study, we investigated whether the LA-ERG waveform is different in ADHD individuals compared to ASD and control individuals.



Fifteen individuals with ADHD (age mean ± SD, 15.3 ± 3.5 years) and fifty-seven participants with ASD (13.7 ± 4.8 years) were recruited. Clinical evaluations were made by specialist paediatric psychiatrists and clinical psychologists in clinics for children with neurodevelopmental disorders at London’s Great Ormond Street Hospital for Children and at local clinics in the UK and South Australia. Diagnostic assessments were supported by parental interviews (the Developmental, Dimensional and Diagnostic Interview, 3Di) [50], school reports and structured observations (Autism Diagnostic Observation Schedule (ADOS)). In this study, we selected children who, after comprehensive clinical evaluation, were considered to meet the diagnostic criteria (DSM-IV, DSM-5 or ICD-10), for ASD without co-occurring ADHD or ADHD without significant ASD traits. Other exclusion criteria included a family history of ocular disease or strabismus, any history of brain trauma or pathology, a history of epileptic seizures in the last year, full-scale IQ < 65 or an ability to follow simple verbal instructions.

Male participants predominated in both groups: ADHD (53%) and ASD (75%). All had normal range intelligence: mean full-scale IQ 92.9 ± 14.2 in ADHD and 100.5 ± 19.4 in ASD. ADHD severity scores were based on the ICD-10 Research Diagnostic Criteria and calculated from measures of hyperactivity, impulsivity and inattention provided by parents/carers and schoolteachers for both ADHD and ASD participants. ADHD severity scores range from 0 (no symptoms) to 6; the mean ADHD severity scores in the ADHD and ASD groups were 3.9 ± 0.8 and 2.0 ± 0.7, respectively (Table 1). The ADOS total scores were used for the analysis, and the ASD severity score was a standardised score calculated from the ADOS total score according to the methods of Gotham et al. [51]. The mean of the ADOS total scores and ASD severity score of the ASD group was 10.9 ± 4.7 and 6.2 ± 2.0, respectively. No ADOS scores were obtained from the ADHD cohort.

Table 1 Participant demographic information

The comorbidities and medications of participants in both cohorts are listed in Additional file 1: Table S1A. Five ADHD participants were tested before and after taking their prescribed methylphenidate medications (see Additional file 1: Table S1B). At the time of testing after taking their medication, the methylphenidate levels in their blood had reached over 80% of maximum and were within the duration of drug action [52,53,54].

Fifty-nine typically developing controls were recruited with no familial history of ASD or ADHD and no diagnosed mental health condition. The control group’s mean age was 13.3 ± 4.6 years. One child had been diagnosed with diabetes. No control participants were taking psychoactive medications, and all had normal or corrected-to-normal visual acuity. Written informed consent was obtained from the parent, guardian or the participant (if older than 16 years of age) in all three groups, and the study was reviewed by the appropriate Institutional Ethics Committees.


The ERG is a clinical test defined by the International Society for Clinical Electrophysiology of Vision (ISCEV) standard [55]. A customised LA full-field ERG series was performed using white light at nine flash strengths (see all the variables in Table 2) that were presented in random order at 2 Hz, on a 40-cd.m−2 white background with an average of 60 trials to obtain the waveform with repeated recordings for both eyes. The nine randomised flash strengths were then followed by the ISCEV standard flash 3.0 cd.s.m−2 on a 30-cd.m−2 white background presented at 2 Hz with 30 samples averaged, to generate the waveform. This custom protocol was programmed in the RETeval (LKC Technologies Inc., Gaithersburg, MD, USA), which was used for all recordings, using a self-adhesive skin electrode positioned 2–3 mm below the participant’s lower eyelid in accordance with the manufacturer’s recommendation. The RETeval automatically stopped recording if pupil tracking was lost (due to poor fixation, pupil size < 1.8mm or the electrode impedance was > 5 kΩ. For further details, see [43, 56].

Table 2 The description of all the variables in the GEE model

Statistical analysis

Data were analysed via generalised estimating equations (GEEs). GEEs are non-likelihood models akin to linear mixed-effects models (LMM) in that they deal with clustered data in cases of repeated measures [57]. GEEs allow defining the family of the response distribution in shapes other than the normal distribution, which is the only option in LMMs [58, 59]. Akin to the goodness-of-fit (GoF) metric Akaike Information Criterion, GEE models’ GoF was assessed via quasi-information criterion (QIC) which is a quasi-likelihood metric under the independence model information criterion [60].

In all models, ‘participants’ as random effects were entered as the vector which identifies clusters, whilst the covariates listed in Table 2 were entered as fixed effects. Models in which the interaction FS•G were significant were further assessed via QIC by retaining significant variables signalled in the full model but leaving out ‘ethnicity’ (see Additional file 1: Table S2). Such examination consisted of 10 repetitions of 10-fold cross-validation was assessed via a Gaussian cross-validation metrics. Non-parametric multiple pairwise comparisons [61] were performed to identify significances amongst the three groups at each flash strength. The aim was to ascertain the combination of flash strength and dependent variable that showed the best potential to differentiate between the groups. The effect of ADHD medications on the ERG measures was analysed to determine if taking medicine before or after (Mba) influenced any of the dependent variables. This analysis was performed via robust linear models. The resulting models were examined via type III ANOVA. If a significant interaction was not present, then the main effects were not analysed further.

The change of b-wave amplitude with flash strength was plotted as the photopic hill and analysed using a mathematical modelling of combinations of a Gaussian function that represents the OFF-pathway and a logistic function that represents ON-pathway contributions according to its parameter maximal Gaussian amplitude (Gb) and maximal saturated amplitude (Vbmax), respectively [62]. As background luminance increases, both components shift to the right on the luminance axis. The Gaussian component increases in amplitude as the logistic growth function component decreased in amplitude. The photopic hill equation model is formulated as follows.

$$y={G}_b\left[{\left(\frac{I}{\mu}\right)}^{\frac{\ln \left(\frac{\mu }{I}\right)}{B^2}}\right]+\frac{V_{b\max }I}{I+{\sigma}_b}$$

All the five parameter values, including the measures of the width of the Gaussian curve (B2), flash strength (I), semi-saturation flash strength (σ), and Gb and Vbmax of each group were generated using non-linear curve-fitting in OriginPro 2019 following the photopic hill equation which was inputted as a customised equation in the Fitting Function Builder. The parameters between the groups were compared by one-way ANOVA. The correlation plot network between the ERG measures and the cohort phenotypes was produced in Origin 2021b.

A p-value < .005 was adopted in all the analyses in this study as a cut-off of statistical significance [63]. All R codes for the analysis, datasets and outputs of this study are available at the FigShare repository (


GEE was performed in this analysis to compare all the ERG parameters in repeated measures amongst the ADHD, control and ASD groups. Additional file 1: Table S2 summarises the effects of each independent variable on the ERG parameters. Further analysis based on the quasi-likelihood theory to examine the interaction (FS•G) of flash strength and the groups demonstrated a statistically significant differences on three variables (see QIC2 in Additional file 1: Table S2). Three ERG variables significantly differentiated the groups (FS•G, df = 18) that these were b-wave amplitude (p = 7.8 × 10−7), b-wave time (p = 1.4 × 10−8) and the p72 amplitude (p = .001).

The finding showed a noticeable elevation of the b-wave amplitude in the ADHD group compared to the control and ASD groups, whereas the ASD b-wave amplitude was reduced compared to comparison control. Figure 3 shows the ERG waveforms for a representative participant from each group at the nine randomised flash strengths.

Fig. 3
figure 3

Comparison of the representative light-adapted ERG waveforms of one individual from each group. The ERG waveforms of each ADHD, control and ASD individual at the nine randomised flash strengths are displayed on the left panel. The right panel enlarges the image of the representative ERG waveforms produced by the 1.204 log phot cd.s.m−2 flash strength, which showed the most significant differences amongst these individuals. The b-wave amplitudes of ADHD are all distinctively higher than both ASD and control individuals at all light strengths. The b-wave amplitudes of ASD are lower than the controls from 0.398 to 1.204 log phot cd.s.m2

b-wave amplitude—ON- and OFF-bipolar cells

Figure 4 displays the medians and 95% CIs of the b-wave amplitudes of the three groups. The median b-wave amplitudes of the ADHD group are significantly higher than those of the control individuals and ASD probands at all flash strengths (all p-values < .005). The photopic hill in Fig. 5 describes the change of the b-wave amplitude against each flash strength. The modelling revealed a significant difference in the two main parameters, maximal saturated amplitude (Vbmax, p < .00001) and maximal Gaussian amplitude (Gb, p = .0038) in ADHD compared to the other groups (see Table 3). The p-values of pairwise comparisons between the groups are listed in Additional file 1: Table S3. Two flash strengths, 0.398 and 1.204 log cd.s.m−2, demonstrated all statistically significant differences between the groups. The b-wave amplitudes of ADHD, control and ASD at 1.204 log cd.s.m−2 were 37.2 ± 10.3 μV, 28.2 ± 8.6 μV and 24.7 ± 8.9μV, respectively (p = 3.98 × 10−12) (see Additional file 1: Table S4A).

Fig. 4
figure 4

Comparison of the b-wave amplitudes of the ADHD, Control and ASD groups. For each flash strength, a set of three boxplots representing ASD, Control and ADHD (from left to right) are displayed. The medians and 95% CIs of each group are presented. The medians of ADHD are distinctively higher than those of the control and ASD groups at all flash strengths

Fig. 5
figure 5

The photopic hill of the b-wave amplitudes of the ADHD, Control and ASD groups. The mean b-wave amplitudes with 95% CIs for each group are plotted at the nine flash strengths

Table 3 Comparison of the photopic hill parameters

b-wave time-to-peak

In all groups, the b-wave time-to-peak gets later as the flash strength increases. The b-wave time-to-peak differed only at some flash strengths by pairwise comparisons amongst the groups (see Additional file 1: Table S3). The main finding was that the higher flash strength of 1.204 log phot cd.s.m−2 produced a faster b-wave time-to-peak for ADHD compared to the ASD groups as the flash strength increased, from 0.398 to 1.204 log cd.s.m−2. The b-wave time-to-peak of ASD is also slower than the control group at the high flash strength of 1.204 log phot cd.s.m−2. However, the differences in the b-wave time-to-peak between the groups were similar at low flash strengths (see Fig. 6 and Additional file 1: Table S4B). The most significant difference in b-time-to-peak was at 1.204 log phot cd.s.m−2 amongst the three groups (p = .001), which the b-time-to-peak of ADHD was 30.6 ± 1.1 ms, compared to 30.8 ± 1.1 ms in Control and 31.2 ± 1.8 ms in the ASD group.

Fig. 6
figure 6

Boxplots showing the comparisons of the b-wave time-to-peak of the ADHD, ASD and Control groups. For each flash strength, a set of three boxplots representing ASD, Control and ADHD (from left to right) are displayed. The medians and 95% CIs of each group are presented

The Photopic Negative Response p72 amplitude—Retinal ganglion cells and Müller cells

Variable differences between the ADHD group and the other groups were found in the PhNR p72 amplitude. Figure 7 shows that the median p72 amplitudes of ADHD were consistently higher than those of the Control and ASD groups at each flash strength (see Additional file 1: Table S4C). The overall significant increases of p72 amplitudes were observed at flash strengths − 0.119 (p = 6.04 × 10−5), 0.398 (p = .0011), 0.477 (p < .001), 1.114 (p = 6.21 × 10−5) and 1.204 log cd.s.m−2 (p = .003) amongst the groups. The p72 amplitudes of ADHD subjects were significantly higher than the other two groups at flash strengths − 0.119 and 1.114 log phot cd.s.m−2. The p72 amplitudes of ADHD, Control and ASD at 1.114 log phot cd.s.m−2 were − 10.6 ± 6.3 μV, − 7.3 ± 3.6 μV and − 7.5 ± 4.5 μV, respectively. However, the PhNR parameters did not distinguish ASD from the control group with no significant differences between these groups (p > .24).

Fig. 7
figure 7

The Photopic Negative Responses (PhNR) at t = 72 ms (p72). The amplitudes of PhNR, p72, of ADHD, Control and ASD groups are shown at all flash strengths. For each flash strength, a set of three boxplots representing ASD, Control and ADHD (from left to right) are displayed. The medians and 95% CIs of each group are presented

For the other ERG measures, no significant differences were observed in each parameter between the ADHD and the other groups in the multiple comparisons, including a-wave time-to-peak (p = .07), a-wave amplitude (p = .17), Tmin (p = .03), PhNRmin (p = .01), p-ratio (p = .01) and w-ratio (p = .02). Additional file 1: Fig. S2 shows the ERG responses of these parameters to all flash strengths in each group.

Direct measurements of the ERGs before and after taking the medication methylphenidate in five ADHD participants did not reveal significant interactions between flash strength and ADHD medication nor other parameters (See FS•Mba in Additional file 1: Table S5, all the p-values are between .011 and .96). Additional file 1: Fig. S3 shows no significant effect of ADHD medications on all the ERG measures.

In addition, no significant correlations between the ADHD and ASD phenotypes or full-scale IQ scores were associated with any of the ERG measures (See Additional file 1: Table S6). Additional file 1: Fig. S4 shows the correlation plot network of all the ERG measures, ASD and ADHD phenotypic variables. The b-wave and p72 amplitudes are directly related to ADHD severity and clusters with ADHD phenotypes.

Specificity and sensitivity of the b-wave amplitude

The most significant differences between the groups for the b-wave amplitude were at the two flash strengths of 0.398 and 1.204 log phot cd.s.m−2 (see the peak and the plateau of the photopic hill in Fig. 5). The b-wave amplitude distinguished the ADHD group from the combined control and ASD group with an area under the receiver operating characteristic curve (AUC ROC) of 0.84 both at 0.398 or 1.204 log phot cd.s.m−2 strengths (see Additional file 1: Fig. S5 and Table S7). The b-wave amplitudes of 36.4 μV and 30.5 μV at 0.398 and 1.204 log phot cd.s.m−2, respectively, are the predicted b-wave amplitude values for ADHD from the combined ASD and control groups, with 80% sensitivity and 71% at 0.398 log phot cd.s.m−2 and sensitivity of 81% and specificity of 70% at 1.204 log phot cd.s.m−2. The AUC for the discrimination of ADHD from ASD was better with the AUC ROC of 0.86 and 0.88 at 0.398 and 1.204 log phot cd.s.m−2, respectively. The b-wave amplitude cut-off points remained the same, with 80% sensitivity and 67% specificity at 0.398 log phot cd.s.m−2, with 84% sensitivity and 57% specificity at 1.204 log phot cd.s.m−2.


This is the first report indicating there are significantly larger LA-ERG b-wave amplitudes in children with ADHD compared to those with ASD or typical development. Whilst participants with ADHD had greater than normal responses, those with ASD had smaller than typical b-wave amplitudes. Thus, the ASD and ADHD phenotypes have opposite ERG b-wave amplitude characteristics compared to controls. Although b-time-to-peak and PhNR p72 amplitudes also differentiated ADHD from the ASD and control groups with statistical significance, the b-wave amplitude provided the greatest discrimination, at two flash strengths. These flash strengths represent the peak and plateau of the photopic hill and are shaped by glutamate driven OFF- and ON-bipolar pathways, respectively [62].

There have been previous reports of a reduced ERG b-wave in ASD which have been considered to be associated with altered kinetics and/or different expression levels of the glutamate receptors and transporters at the cone-bipolar-horizontal cell synapse [42, 43]. An ASD mouse model shows a significant structural reduction of photoreceptor and bipolar cell markers, as well as functional defects of the significantly reduced a-wave and b-wave amplitudes compared to controls [64]. The change in the timings of the summation of excitatory and inhibitory signals and hence reduction of the b-wave amplitudes in ASD are linked to an imbalance of glutamate and GABA activities [28, 49, 65]. Research studies have investigated whether there are reduced GABA-A receptors in the ASD brain using both human and mouse models [66]. There were no differences in the GABA-A receptors in any brain region of adults with ASD as well as in any of the ASD mouse models, although adults with ASD displayed alterations in performance during a GABA-sensitive perceptual task [66]. The results suggested that GABA-A receptor availability could be normal in ASD despite the functionally impaired GABA signalling [66]. Post-mortem studies in ASD report abnormalities in the expression of glutamate transporters, GABA-A and GABA-B receptors [67, 68]. Another study has shown an imbalance of excitatory/inhibitory gene expression in ASD but demonstrated that reduced expression of inhibitory genes was more pronounced than those genes related to excitation. It was suggested that the imbalance in ASD was mainly due to GABA disturbances [49, 69].

Variants in the GABAergic gene sets have been reported to be more associated with ASD than ADHD, whereas glutamate gene set activity showed association with ADHD hyperactivity-impulsivity symptoms [49]. A genome-wide copy number variation (CNV) study has identified enrichment of CNVs in metabotropic glutamate receptor gene networks that were overrepresented in cases with ADHD compared to controls, and the findings were replicated in multiple ADHD cohorts [70]. The levels of serum glutamate were two times higher and that of GABA were lower in children with ADHD [71, 72]. Additionally, a research study showed an association of GABA with response inhibition [73]. Many studies using magnetic resonance spectroscopy have reported abnormal levels of glutamate and glutamate/glutamine (Glx) in ADHD adults compared to controls—such as increased glutamate in the cerebellum [74], higher level of striatal glutamate and Glx concentration [49, 75], reduced Glx in the caudate/putamen [7] and reduced glutamate/creatine in both the medial post-frontal cortex and the anterior cingulate cortex [76, 77]. These findings suggest a role for glutamate concentration in fronto-striatal neural functioning during cognitive control [78]. Although a recent study has shown no differences in glutamate and GABA concentration in the anterior cingulate cortex between children with ADHD and controls, glutamate or GABAergic differences in the subregions have not been ruled out [79]. All these findings indicate GABAergic and glutamatergic dysregulation in ADHD. Interestingly, increased glutamate release has been reported from the prefrontal cortex of the spontaneously hyperactive rat [80, 81]. These observations indicate an imbalance of glutamatergic and GABAergic neurotransmission in both ADHD and ASD, and there seems to be greater glutamatergic dysregulation in ADHD and more GABA disturbances in ASD. The nature of that imbalance differentiates these conditions by the alterations of the b-wave formation in reverse direction as demonstrated in this study.

Larger b-wave amplitudes in ADHD could be explained by a lower signal threshold in response to a light flash, and the observation is compatible with other findings of an increase in retinal neuronal noise or non-stimulus driven neuronal activity in ADHD [1, 46]. Elevated neural noise can enhance cell threshold systems by allowing a signal to reach the threshold at intermediate noise intensities through stochastic resonance or facilitation [82]. This typically enhances low signals, which are produced in the retina to dim flash strengths. In ADHD, it is plausible that an abnormal interplay between response mechanisms contributes to the stochastic resonance that extends across the entire signalling range of the retinal cone networks [83]. The timing of the ionotropic synapse (OFF-response) can be changed by glutamate receptor auxillary subunits [84, 85]. The photopic hill model in Fig. 5 implies lower signal thresholds in ADHD exist across all the flash strengths with a stronger influence of the ON-pathway (p < .00001) compared to the OFF-pathway (p = .0038).

A significantly larger PhNR p72 amplitude was observed in the ADHD than in the control group at the higher flash strengths. In contrast, there were no significant differences in any of the PhNR parameters between the ASD and control groups. This finding had previously been reported [56] and confirms the marker does not clearly discriminate between these clinical conditions. The PhNR parameters are associated with the retinal ganglion cell activity which can be also measured from the central retina using the Pattern ERG. Notwithstanding, neither b-wave time-to-peak or PhNRp72 parameters were as significant as the b-wave amplitude in differentiating ADHD from ASD.

Several studies have examined the signalling interactions between dopamine and glutamate in ADHD [48, 86, 87]. Dopamine acts in the retina as a neurotransmitter for laterally connecting cells, such as horizontal cells and some amacrine cells. Dopaminergic activity in the visual system is reduced in Parkinson’s disease and is characterised by a diminished b-wave amplitude [88,89,90], implying abnormalities in dopamine signalling could provide an explanation for our findings. In humans, the administration of L-DOPA increases the b-wave amplitude and that observation is consistent with the finding that increasing dopamine levels with methylphenidate reduces retinal noise and improves clinical symptoms in ADHD [46]. We therefore anticipated a relationship might have been found between b-wave amplitude and the administration of systemic methylphenidate. In a small subsample of children with ADHD, we repeated the ERG measures before and after methylphenidate administration and found elevated b-wave amplitudes distinguished ADHD from ASD, regardless of systemic methylphenidate levels. The signalling interaction between dopaminergic and glutamatergic systems for the large b-wave is unlikely to account for the larger b-wave in ADHD.

Measuring the severity of ASD and ADHD from a combination of parental/school reports and observation, we did not find any significant association with either b-wave amplitudes or PhNR parameters. Nor did we find any association between these variables and other ERG measures. ERG parameters were independent of both ASD and ADHD severity as well as measures of intelligence, although there was a stronger relationship between the ERG parameters and the ADHD phenotypes.


The sample of children with ADHD was small, in part because of our stringency to exclude any participant with associated ASD traits. Replication studies with a larger ADHD sample size across a wider age range could identify the age at which ERG abnormalities emerge, and track their development over time, especially in later adolescence and early adulthood. Collecting a complete set of phenotypic data in all three groups will improve the understanding of the relationship between the ERG measures and the phenotypes. The relationship between ADHD symptoms and biological sex is known to be complex, with evidence that in girls, the phenotype is more inattentive in character and thus clinically elusive [91]. A larger sex-matched sample should allow the investigation of the ERG as a potential biomarker in girls for whom the diagnosis of ADHD is uncertain. Our findings did not indicate any impact of stimulant medication on retinal dysfunction, but this observation needs to be replicated with a larger sample because there is potentially an influence of the retina’s dopaminergic network on the b-wave amplitude. Other non-stimulant medications, such as atomoxetine, should also be assessed. Exploring higher flash strengths may reveal greater group differences, but this would require pupil dilation to increase retinal illumination. We deliberately selected ASD and ADHD cohorts in this study that did not have clinically significant traits of both conditions. We also excluded children with significant emotional or behavioural comorbidities. Substantial proportions of clinically identified children with both ASD and ADHD have combined neurodevelopmental disorders as well as other mental health disorders; our protocol should be extended to investigate these conditions in combination too.


This study was the first to present the observation, from a robust light-adapted ERG measure, that increases in b-wave amplitude can distinguish children with ADHD from those with ASD and typical controls. The observation of a diametrically opposite pattern of b-wave response in the two conditions implies a biomarker exists that correlates with their clinical characteristics. Consequently, the ERG waveform appears to be a physiological marker that could potentially support their differential diagnosis. Whilst the biological significance of the retinal response requires further investigation, our findings imply the differentiation between the clinically related conditions ASD and ADHD could lie in the balance between the activities of glutamatergic and GABAergic neurotransmitter systems.

Availability of data and materials

The datasets, the R codes for the analysis and other analytical outputs of this study are available in the FigShare repository (



The Developmental, Dimensional and Diagnostic Interview


a-wave amplitude


Attention Deficit Hyperactivity Disorder


Autism Diagnostic Observation Schedule


α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid


Autism Spectrum Disorder


a-wave time-to-peak


Area Under the Curve


b-wave amplitude


b-wave time-to-peak


Confidence Interval


Copy Number Variant


The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition


The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition




Gamma-aminobutyric Acid


Generalised Estimating Equations




International Statistical Classification of Diseases and Related Health Problems, Tenth Revision


Ionotropic Glutamate Receptor 4


Intelligence Quotient


International Society of Clinical Electrophysiology of Vision




Light-adapted Electroretinogram


ISCEV standard flash 3.0 cd.s.m−2


Metabotropic Glutamate Receptor


Electroretinogram device from LKC Technologies Inc., USA


Photopic Negative Response


Receiver Operating Characteristic


Transient Receptor Potential cation channel subfamily M member 1


  1. Bubl E, Dörr M, Riedel A, Ebert D, Philipsen A, Bach M, et al. Elevated background noise in adult attention deficit hyperactivity disorder is associated with inattention. PLoS One. 2015;10(2):e0118271.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–8.

    Article  PubMed  Google Scholar 

  3. Polanczyk G, Jensen P. Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update. Child Adolesc Psychiatr Clin N Am. 2008;17(2):245–60 vii.

    Article  PubMed  Google Scholar 

  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Publishing; 2013.

    Book  Google Scholar 

  5. Wasserstein J. Diagnostic issues for adolescents and adults with ADHD. J Clin Psychol. 2005;61(5):535–47.

    Article  PubMed  Google Scholar 

  6. Low AM, Vangkilde S, le Sommer J, Fagerlund B, Glenthoj B, Jepsen JRM, et al. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment. Psychol Med. 2019;49(15):2617–25.

    Article  PubMed  Google Scholar 

  7. Maltezos S, Horder J, Coghlan S, Skirrow C, O’Gorman R, Lavender TJ, et al. Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study. Transl Psychiatry. 2014;4:e373.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007;104(49):19649–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hoekzema E, Carmona S, Ramos-Quiroga JA, Richarte Fernandez V, Picado M, Bosch R, et al. Laminar thickness alterations in the fronto-parietal cortical mantle of patients with attention-deficit/hyperactivity disorder. PLoS One. 2012;7(12):e48286.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Fuermaier ABM, Hupen P, De Vries SM, Muller M, Kok FM, Koerts J, et al. Perception in attention deficit hyperactivity disorder. Atten Defic Hyperact Disord. 2018;10(1):21–47.

    Article  PubMed  Google Scholar 

  11. Kim S, Al-Haj M, Chen S, Fuller S, Jain U, Carrasco M, et al. Colour vision in ADHD: part 1--testing the retinal dopaminergic hypothesis. Behav Brain Funct. 2014;10:38.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Müller CP, Huston JP. Dopamine activity in the occipital and temporal cortices of rats: dissociating effects of sensory but not pharmacological stimulation. Synapse. 2007;61(4):254–8.

    Article  PubMed  CAS  Google Scholar 

  13. Kim S, Chen S, Tannock R. Visual function and color vision in adults with attention-deficit/hyperactivity disorder. J Optom. 2014;7(1):22–36.

    Article  PubMed  Google Scholar 

  14. Robertson AE, David RSR. The sensory experiences of adults with autism spectrum disorder: a qualitative analysis. Perception. 2015;44(5):569–86.

    Article  PubMed  Google Scholar 

  15. Lim L, Chantiluke K, Cubillo AI, Smith AB, Simmons A, Mehta MA, et al. Disorder-specific grey matter deficits in attention deficit hyperactivity disorder relative to autism spectrum disorder. Psychol Med. 2015;45(5):965–76.

    Article  CAS  PubMed  Google Scholar 

  16. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47(8):921–9.

    Article  PubMed  Google Scholar 

  17. Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry. 2010;19(3):281–95.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Schatz AM, Weimer AK, Trauner DA. Brief report: attention differences in Asperger syndrome. J Autism Dev Disord. 2002;32(4):333–6.

    Article  PubMed  Google Scholar 

  19. Geurts HM, Verte S, Oosterlaan J, Roeyers H, Sergeant JA. How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? J Child Psychol Psychiatry. 2004;45(4):836–54.

    Article  PubMed  Google Scholar 

  20. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM-IV. 4th ed. Washington, DC: American Psychiatric Association Publishing; 2000.

  21. London A, Inbal Benhar I, Schwartz M. The retina as a window to the brain—from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44–53.

    Article  CAS  PubMed  Google Scholar 

  22. De Groef L, Cordeiro MF. Is the eye an extension of the brain in central nervous system disease? J Ocul Pharmacol Ther. 2018;34(1-2):129–33.

    Article  PubMed  CAS  Google Scholar 

  23. Kashani AH, Asanad S, Chan JW, Singer MB, Zhang J, Sharifi M, et al. Past, present and future role of retinal imaging in neurodegenerative disease. Prog Retin Eye Res. 2021;100938:1–38.

  24. Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, et al. Retinal imaging in Alzheimer’s and neurodegenerative diseases. Alzheimers Dement. 2021;17(1):103–11.

    Article  CAS  PubMed  Google Scholar 

  25. Zhang Y, Wang Y, Shi C, Shen M, Lu F. Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease. Transl Neurodegener. 2021;10(1):6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Youssef P, Nath S, Chaimowitz GA, Prat SS. Electroretinography in psychiatry: a systematic literature review. Eur Psychiatry. 2019;62:97–106.

    Article  PubMed  Google Scholar 

  27. Rojas JC, Marin-Morales J, Ausin Azofra JM, Contero M. Recognizing decision-making using eye movement: a case study with children. Front Psychol. 2020;11:570470.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Chapot CA, Euler T, Schubert T. How do horizontal cells ‘talk’ to cone photoreceptors? Different levels of complexity at the cone-horizontal cell synapse. J Physiol. 2017;595(16):5495–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Thoreson WB, Mangel SC. Lateral interactions in the outer retina. Prog Retin Eye Res. 2012;31(5):407–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Hirano AA, Vuong HE, Kornmann HL, Schietroma C, Stella SL Jr, Barnes S, et al. Vesicular release of GABA by mammalian horizontal cells mediates inhibitory output to photoreceptors. Front Cell Neurosci. 2020;14:600777.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Schneider FM, Mohr F, Behrendt M, Oberwinkler J. Properties and functions of TRPM1 channels in the dendritic tips of retinal ON-bipolar cells. Eur J Cell Biol. 2015;94(7-9):420–7.

    Article  CAS  PubMed  Google Scholar 

  32. Spileers W, Falcao-Reis F, Hogg C, Arden GB. Evidence from human electroretinogram A and off responses that color processing occurs in the cones. Invest Ophthalmol Vis Sci. 1993;34(6):2079–91.

    CAS  PubMed  Google Scholar 

  33. Viswanathan S, Frishman LJ, Robson JG, Harwerth RS, Smith EL 3rd. The photopic negative response of the macaque electroretinogram: reduction by experimental glaucoma. Invest Ophthalmol Vis Sci. 1999;40(6):1124–36.

    CAS  PubMed  Google Scholar 

  34. Machida S. Clinical applications of the photopic negative response to optic nerve and retinal diseases. J Ophthalmol. 2012;2012:397178.

    PubMed  PubMed Central  Google Scholar 

  35. Thompson DA, Feather S, Stanescu HC, Freudenthal B, Zdebik AA, Warth R, et al. Altered electroretinograms in patients with KCNJ10 mutations and EAST syndrome. J Physiol. 2011;589(Pt 7):1681–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Hébert M, Mérette C, Gagné AM, Paccalet T, Moreau I, Lavoie J, et al. The electroretinogram may differentiate schizophrenia from bipolar disorder. Biol Psychiatry. 2020;87(3):263–70.

    Article  PubMed  Google Scholar 

  37. Hébert M, Merette C, Paccalet T, Gagné AM, Maziade M. Electroretinographic anomalies in medicated and drug free patients with major depression: tagging the developmental roots of major psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2017;75:10–5.

    Article  PubMed  Google Scholar 

  38. Hebert M, Merette C, Paccalet T, Emond C, Gagne AM, Sasseville A, et al. Light evoked potentials measured by electroretinogram may tap into the neurodevelopmental roots of schizophrenia. Schizophr Res. 2015;162(1-3):294–5.

    Article  PubMed  Google Scholar 

  39. Bernardin F, Schwitzer T, Schwan R, Angioi-Duprez K, Ligier F, Bourion-Bedes S, et al. Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia. Schizophr Res. 2021;239:134–41.

    Article  PubMed  Google Scholar 

  40. Maziade M, Bureau A, Jomphe V, Gagne AM. Retinal function and preclinical risk traits in children and adolescents at genetic risk of schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2022;112:110432.

    Article  CAS  PubMed  Google Scholar 

  41. Fradkin SI, Erickson MA, Demmin DL, Silverstein SM. Absence of excess intra-individual variability in retinal function in people with schizophrenia. Front Psychiatry. 2020;11:543963.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Constable PA, Gaigg SB, Bowler DM, Jagle H, Thompson DA. Full-field electroretinogram in autism spectrum disorder. Doc Ophthalmol. 2016;132(2):83–99.

    Article  PubMed  Google Scholar 

  43. Constable PA, Ritvo ER, Ritvo AR, Lee IO, McNair ML, Stahl D, et al. Light-adapted electroretinogram differences in autism spectrum disorder. J Autism Dev Disord. 2020;50(8):2874–85.

    Article  PubMed  Google Scholar 

  44. Constable PA, Gaigg SB, Bowler DM, Thompson DA. Motion and pattern cortical potentials in adults with high-functioning autism spectrum disorder. Doc Ophthalmol. 2012;125(3):219–27.

    Article  PubMed  Google Scholar 

  45. Ritvo ER, Creel D, Realmuto G, Crandall AS, Freeman BJ, Bateman JB, et al. Electroretinograms in autism: a pilot study of b-wave amplitudes. Am J Psychiatry. 1988;145(2):229–32.

    Article  CAS  PubMed  Google Scholar 

  46. Werner AL, Tebartz van Elst L, Ebert D, Friedel E, Bubl A, Clement HW, et al. Normalization of increased retinal background noise after ADHD treatment: a neuronal correlate. Schizophr Res. 2020;219:77–83.

    Article  PubMed  Google Scholar 

  47. Dommett EJ, Overton PG, Greenfield SA. Drug therapies for attentional disorders alter the signal-to-noise ratio in the superior colliculus. Neuroscience. 2009;164(3):1369–76.

    Article  CAS  PubMed  Google Scholar 

  48. Huang X, Wang M, Zhang Q, Chen X, Wu J. The role of glutamate receptors in attention-deficit/hyperactivity disorder: from physiology to disease. Am J Med Genet B Neuropsychiatr Genet. 2019;180(4):272–86.

    Article  CAS  PubMed  Google Scholar 

  49. Naaijen J, Bralten J, Poelmans G, consortium I, Glennon JC, Franke B, et al. Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism. Transl Psychiatry. 2017;7(1):e999.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Skuse D, Warrington R, Bishop D, Chowdhury U, Lau J, Mandy W, et al. The developmental, dimensional and diagnostic interview (3di): a novel computerized assessment for autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2004;43(5):548–58.

    Article  PubMed  Google Scholar 

  51. Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009;39(5):693–705.

    Article  PubMed  Google Scholar 

  52. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics. 2001;107(6):E105.

    Article  CAS  PubMed  Google Scholar 

  53. Harpin V. The management of ADHD in children and young people. London: Mac Keith Press; 2017.

    Google Scholar 

  54. Coghill D, Banaschewski T, Zuddas A, Pelaz A, Gagliano A, Doepfner M. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry. 2013;13:237.

    Article  PubMed  PubMed Central  Google Scholar 

  55. McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, et al. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015;130(1):1–12.

    Article  PubMed  Google Scholar 

  56. Constable PA, Lee IO, Marmolejo-Ramos F, Skuse DH, Thompson DA. The photopic negative response in autism spectrum disorder. Clin Exp Optom. 2021;104(8):841–7.

  57. Pekár S, Brabec M. Generalized estimating equations: a pragmatic and flexible approach to the marginal GLM modelling of correlated data in the behavioural sciences. Ethology. 2018;124:86–93.

  58. Højsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1–11.

  59. Hubbard AE, Ahern J, Fleischer NL, Van der Laan M, Lippman SA, Jewell N, et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology. 2010;21(4):467–74.

    Article  PubMed  Google Scholar 

  60. Pan W. Akaike’s Information Criterion in generalized estimating equations. Biometrics. 2001;57:120–5.

    Article  CAS  PubMed  Google Scholar 

  61. Noguchi K, Abel RS, Marmolejo-Ramos F, Konietschke F. Nonparametric multiple comparisons. Behav Res Methods. 2020;52(2):489–502.

    Article  PubMed  Google Scholar 

  62. Hamilton R, Bees MA, Chaplin CA, McCulloch DL. The luminance-response function of the human photopic electroretinogram: a mathematical model. Vision Res. 2007;47(23):2968–72.

    Article  CAS  PubMed  Google Scholar 

  63. Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers E-J, Berk R, et al. Redefine statistical significance. Nat Hum Behav. 2018;2(1):6–10.

    Article  PubMed  Google Scholar 

  64. Zhang X, Piano I, Messina A, D’Antongiovanni V, Cro F, Provenzano G, et al. Retinal defects in mice lacking the autism-associated gene Engrailed-2. Neuroscience. 2019;408:177–90.

    Article  CAS  PubMed  Google Scholar 

  65. Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, et al. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. 2018;136(1):1–26.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Horder J, Andersson M, Mendez MA, Singh N, Tangen A, Lundberg J, et al. GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models. Sci Transl Med. 2018;10(461):eaam8434.

    Article  PubMed  CAS  Google Scholar 

  67. Fatemi SH, Folsom TD, Reutiman TJ, Thuras PD. Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum. 2009;8(1):64–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD. GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord. 2009;39(2):223–30.

    Article  PubMed  Google Scholar 

  69. van de Lagemaat LN, Nijhof B, Bosch DG, Kohansal-Nodehi M, Keerthikumar S, Heimel JA. Age-related decreased inhibitory vs. excitatory gene expression in the adult autistic brain. Front Neurosci. 2014;8:394.

    PubMed  PubMed Central  Google Scholar 

  70. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D, et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet. 2011;44(1):78–84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Bollmann S, Ghisleni C, Poil SS, Martin E, Ball J, Eich-Hochli D, et al. Developmental changes in gamma-aminobutyric acid levels in attention-deficit/hyperactivity disorder. Transl Psychiatry. 2015;5:e589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Gilgun JF. The NEATS: a child & family assessment. null ed. USA: CreateSpace Independent Publishing Platform; 2011.

    Google Scholar 

  73. Silveri MM, Sneider JT, Crowley DJ, Covell MJ, Acharya D, Rosso IM, et al. Frontal lobe gamma-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition. Biol Psychiatry. 2013;74(4):296–304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Perlov E, Tebarzt van Elst L, Buechert M, Maier S, Matthies S, Ebert D, et al. H(1)-MR-spectroscopy of cerebellum in adult attention deficit/hyperactivity disorder. J Psychiatr Res. 2010;44(14):938–43.

    Article  CAS  PubMed  Google Scholar 

  75. Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2007;17(1):11–7.

    Article  PubMed  Google Scholar 

  76. Dramsdahl M, Ersland L, Plessen KJ, Haavik J, Hugdahl K, Specht K. Adults with attention-deficit/hyperactivity disorder - a brain magnetic resonance spectroscopy study. Front Psychiatry. 2011;2:65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Perlov E, Philipsen A, Hesslinger B, Buechert M, Ahrendts J, Feige B, et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder -- a magnet resonance spectroscopy study. J Psychiatr Res. 2007;41(11):934–41.

    Article  CAS  PubMed  Google Scholar 

  78. Naaijen J, Lythgoe DJ, Zwiers MP, Hartman CA, Hoekstra PJ, Buitelaar JK, et al. Anterior cingulate cortex glutamate and its association with striatal functioning during cognitive control. Eur Neuropsychopharmacol. 2018;28(3):381–91.

    Article  CAS  PubMed  Google Scholar 

  79. Hai T, Swansburg R, Kahl CK, Frank H, Lemay JF, MacMaster FP. Magnetic resonance spectroscopy of gamma-aminobutyric acid and glutamate concentrations in children with attention-deficit/hyperactivity disorder. JAMA Netw Open. 2020;3(10):e2020973.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Miller EM, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE. Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Psychopharmacology (Berl). 2014;231(15):3019–29.

    Article  CAS  Google Scholar 

  81. Russell VA. Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci. 2011;Chapter 9:Unit 9.35.

  82. Faisal AA, Selen LP, Wolpert DM. Noise in the nervous system. Nat Rev Neurosci. 2008;9(4):292–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Guo D, Perc M, Liu T, Yao D. Functional importance of noise in neuronal information processing. EPL. 2018;124(50001):1–7.

    Google Scholar 

  84. Stern P. Timing counts for whisker development. Science. 2014;345(6204):1575 American Association for the Advancement of Science.

    Google Scholar 

  85. Shanks NF, Cais O, Maruo T, Savas JN, Zaika EI, Azumaya CM, et al. Molecular dissection of the interaction between the AMPA receptor and cornichon homolog-3. J Neurosci. 2014;34(36):12104–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, et al. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron. 2002;35(6):1111–22.

    Article  CAS  PubMed  Google Scholar 

  87. Yuen EY, Zhong P, Yan Z. Homeostatic regulation of glutamatergic transmission by dopamine D4 receptors. Proc Natl Acad Sci U S A. 2010;107(51):22308–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD). Doc Ophthalmol. 2015;131(2):95–104.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Gottlob I, Schneider E, Heider W, Skrandies W. Alteration of visual evoked potentials and electroretinograms in Parkinson’s disease. Electroencephalogr Clin Neurophysiol. 1987;66(4):349–57.

    Article  CAS  PubMed  Google Scholar 

  90. Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vision Res. 1994;34(19):2629–38.

    Article  CAS  PubMed  Google Scholar 

  91. Mowlem F, Agnew-Blais J, Taylor E, Asherson P. Do different factors influence whether girls versus boys meet ADHD diagnostic criteria? Sex differences among children with high ADHD symptoms. Psychiatry Res. 2019;272:765–73.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


The authors would like to thank the participants and their families for their support. The authors thank LKC Technologies for programming the RETeval custom protocol used in this study.


This research project was funded by a generous personal donation from Emeritus Professor Edward R. Ritvo and the Alan B Slifka foundation.

Author information

Authors and Affiliations



DS, DT, IL and PC conceived the study. DT and PC designed the methodology of the project. IL and PC were responsible for recruiting, collecting and analysing the data. DS contributed the clinical data of ADHD and ASD cohorts. FM-R and LO were responsible for analysing the data. IL wrote the first draft of the manuscript. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Irene O. Lee.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the South East Scotland Research Ethics Committee in the UK and the Flinders University Human Research Ethics Committee in Australia. Written informed consent was obtained from the parents/caregivers of children under the age of 16 or from the participants over the age of 16 who took part in this study.

Consent for publication

Not applicable. No identifiable personal data has been used in this manuscript.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Comorbidities and medications. Fig. S1. Iris colour index. Table S2. Generalised estimating equations analysis of all the variables. Table S3. Pairwise comparisons between groups. Table S4. The b-wave amplitude, b-time-to-peak and p72 values. Fig. S2. Summary of the ERG measures. Table S5. The effects of ADHD medications. Fig. S3. The effects of ADHD medications on ERG measures. Table S6. Correlations of the ERG measures and phenotypes. Fig. S4. Correlation plot network. Fig. S5. ROC Curve. Table S7. Comparisons of AUC, Cut-off point, Specificity and Sensitivity.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, I.O., Skuse, D.H., Constable, P.A. et al. The electroretinogram b-wave amplitude: a differential physiological measure for Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. J Neurodevelop Disord 14, 30 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: